Alternative finance becoming more mainstream
Concerns about US rate rise impact on EMs
Diversifying portfolios
Geoffrey C. Hsu, partner of OrbiMed and manager of the BiotechGrowth trust, assesses the key drivers for the sector in 2016 and beyond.
Long term succession planning
Aviva Investors' head of multi-asset Peter Fitzgerald takes a closer look at the impact of commodity cycles on markets.
Fidelity's multi-asset manager Eugene Philalithis reveals his three strategies for protecting portfolios from duration risk, ahead of rate rises in the UK and US.